Type 2 Diabetes Mellitus and Chronic Obstructive Pulmonary Disease - from Pathophysiology to Effective Management
Victor Prisacaru1, Serghei Covantsev2, Alexandr Ceasovschih3
1Department of Endocrinology, Nicolae Testemitanu State University of Medicine and Pharmacy, Municipal Clinical Hospital No. 1 "Gheorghe Palade", Chisinau, Republic of Moldova.
Abstract:
Type 2 diabetes mellitus (T2DM) and chronic obstructive pulmonary disease (COPD) are two chronic conditions with significant global impact and high incidence, frequently occurring as comorbidities. This article analyzes the particularities of pathophysiological, genetic, and epigenetic interactions, as well as the therapeutic implications in patients with both conditions. Additionally, the clinical management of these patients is investigated in correlation with updated international guidelines, such as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 and the American Diabetes Association (ADA) 2026. The importance of rigorous monitoring, personalized treatment, and the use of modern therapies with proven benefits-including sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 (GLP-1) receptor agonists-is highlighted. The conclusion emphasizes the necessity of an integrated, multidisciplinary approach aimed at preventing complications, reducing cardiovascular risk, and improving the quality of life in comorbid patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes II: Pathophysiology
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Type II Diabetes I: Introduction
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

